Beginning of the end of hepatitis B in Australia?

Beginning of the end of hepatitis B in Australia?
Hepatitis B virus in between human cells.

(Medical Xpress)—A newborn vaccination program first introduced for Aboriginal babies in the Northern Territory has made significant inroads, significantly helping in the push to eradicate chronic hepatitis B infection in Australia.

Researchers from UNSW's Kirby Institute and the Northern Territory's Department of Health have published a study in the international journal Vaccine that shows rates of infection are 80 per cent lower in young Aboriginal women born since the program began in 1988, compared to those born before the program began.

In Aboriginal women from remote communities, the decrease has seen rates fall from five per cent to one per cent, the study, conducted by UNSW's Kirby Institute in collaboration with the Northern Territory Department of Health, shows.

Researchers say it may be expected that a similar decline will be seen in other Australian states and territories once children vaccinated from 2000 onwards become old enough to be included in hepatitis B testing programs.

Hepatitis B is a potentially life-threatening infection that causes liver cirrhosis, and .

The study findings highlight the importance of immunisation programs in preventing chronic diseases such as hepatitis B, the researchers say.

Related Stories

Hepatitis B and liver cancer among Asian Americans

date Jun 21, 2012

(Medical Xpress) -- Liver cancer is expected to become more common in the United States in coming years.  “It’s deadly and it’s preventable,” says UCSF physician and researcher Tung ...

Recommended for you

Score IDs patients with upper extremity DVT at low risk

date 5 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date 15 hours ago

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date 15 hours ago

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.